Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis

Treatment of rheumatoid arthritis (RA) is aimed at long-term remission and inhibition of joint destruction by different biologic drugs. However, the choice of a particular biologic agent based on individual cases of RA remains unestablished. Interleukin-6 (IL-6) inhibitor and tumor necrosis factor (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Hayashi, Shinya, Matsubara, Tsukasa, Fukuda, Koji, Funahashi, Keiko, Hashimoto, Marowa, Maeda, Toshihisa, Kamenaga, Tomoyuki, Takashima, Yoshinori, Matsumoto, Tomoyuki, Niikura, Takahiro, Kuroda, Ryosuke
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7538428/
https://ncbi.nlm.nih.gov/pubmed/33024253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73968-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi